HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jennifer R Grandis Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

12/2013Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma.
10/2011Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jennifer R Grandis Research Topics

Disease

149Neoplasms (Cancer)
01/2024 - 06/2003
127Squamous Cell Carcinoma of Head and Neck
10/2023 - 10/2003
65Head and Neck Neoplasms (Head and Neck Cancer)
10/2023 - 09/2005
17Carcinogenesis
01/2023 - 03/2005
8Neoplasm Metastasis (Metastasis)
01/2023 - 08/2005
7Lung Neoplasms (Lung Cancer)
05/2015 - 09/2006
6Carcinoma (Carcinomatosis)
01/2023 - 11/2004
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024 - 01/2014
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2013 - 02/2005
3Papillomavirus Infections
11/2018 - 10/2014
3Hypoxia (Hypoxemia)
01/2017 - 11/2009
3Mouth Neoplasms (Oral Cancer)
08/2016 - 07/2010
3Lymphatic Metastasis
01/2016 - 09/2006
3Glioblastoma (Glioblastoma Multiforme)
09/2014 - 09/2006
3Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2013 - 06/2008
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 12/2015
2Triple Negative Breast Neoplasms
02/2019 - 01/2016
2Disease Progression
01/2017 - 10/2014

Drug/Important Bio-Agent (IBA)

64ErbB Receptors (EGF Receptor)IBA
01/2024 - 06/2003
43Cetuximab (Erbitux)FDA Link
11/2021 - 09/2006
31Proteins (Proteins, Gene)FDA Link
11/2021 - 10/2007
28Biomarkers (Surrogate Marker)IBA
10/2023 - 03/2005
15Tyrosine Kinase InhibitorsIBA
01/2022 - 06/2003
15Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2017 - 07/2007
14Monoclonal AntibodiesIBA
11/2020 - 06/2003
13Phosphotransferases (Kinase)IBA
01/2020 - 11/2004
11Cisplatin (Platino)FDA LinkGeneric
01/2023 - 09/2006
11STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2019 - 03/2008
11DNA (Deoxyribonucleic Acid)IBA
10/2018 - 07/2010
8Small Interfering RNA (siRNA)IBA
01/2024 - 06/2008
8Messenger RNA (mRNA)IBA
10/2021 - 06/2008
7OligonucleotidesIBA
01/2020 - 05/2009
7Interleukin-6 (Interleukin 6)IBA
01/2020 - 10/2011
7LigandsIBA
12/2019 - 06/2006
6Transcription Factors (Transcription Factor)IBA
01/2023 - 08/2012
6RNA (Ribonucleic Acid)IBA
01/2023 - 10/2014
6Tyrosine (L-Tyrosine)FDA Link
01/2019 - 06/2007
5EnzymesIBA
01/2023 - 03/2013
5Immune Checkpoint InhibitorsIBA
10/2021 - 09/2016
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2021 - 06/2005
5CytokinesIBA
01/2021 - 03/2005
5NucleotidesIBA
01/2020 - 02/2013
5src-Family KinasesIBA
01/2017 - 07/2008
5Gefitinib (Iressa)FDA Link
07/2011 - 02/2005
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2021 - 09/2004
4Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
06/2020 - 06/2009
4Janus KinasesIBA
01/2020 - 06/2005
4Dasatinib (BMS 354825)FDA Link
01/2017 - 05/2012
4epidermal growth factor receptor VIIIIBA
01/2015 - 09/2006
4Cyclin D1IBA
01/2015 - 04/2005
4Epidermal Growth Factor (EGF)IBA
04/2014 - 07/2008
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2013 - 09/2004
3AlpelisibIBA
10/2023 - 01/2019
3Tumor Biomarkers (Tumor Markers)IBA
01/2023 - 01/2018
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022 - 01/2019
3Caspase 8 (Caspase-8)IBA
01/2021 - 10/2014
3Mechanistic Target of Rapamycin Complex 1IBA
02/2019 - 11/2012
3Oncogene Proteins (Oncogene Protein)IBA
01/2018 - 10/2014
3AntibodiesIBA
09/2016 - 05/2012
3CarcinogensIBA
08/2016 - 04/2005
3Protein Tyrosine PhosphatasesIBA
05/2016 - 01/2014
3Annexin A5IBA
02/2014 - 10/2007
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2014 - 01/2008
3Indicators and Reagents (Reagents)IBA
01/2014 - 02/2011
3Bombesin Receptors (Bombesin Receptor)IBA
02/2013 - 03/2008
3Proteasome InhibitorsIBA
12/2012 - 06/2008
3Bortezomib (Velcade)FDA Link
12/2012 - 06/2008
2tipifarnib (R115777)IBA
10/2023 - 01/2023
2Dinoprostone (PGE2)FDA Link
01/2023 - 01/2020
2Protein Kinases (Protein Kinase)IBA
10/2021 - 11/2018
2Protein Isoforms (Isoforms)IBA
10/2021 - 05/2021
2Lysine (L-Lysine)FDA Link
01/2021 - 06/2008
2Doxycycline (Periostat)FDA LinkGeneric
01/2021 - 11/2018
2sulforaphaneIBA
12/2019 - 07/2016
2Gastrin-Releasing PeptideIBA
11/2018 - 02/2009
2matrigelIBA
11/2018 - 07/2008
2Antisense DNAIBA
10/2018 - 03/2009
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018 - 06/2017
2Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2018 - 01/2014
2Antineoplastic Agents (Antineoplastics)IBA
01/2018 - 04/2014
2tyrosine receptor (receptor, tyrosine)IBA
01/2018 - 06/2008
2Mitogen-Activated Protein KinasesIBA
01/2017 - 09/2012
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2017 - 12/2008
2TOR Serine-Threonine KinasesIBA
12/2016 - 11/2012
24-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA
07/2016 - 02/2011
2MicroRNAs (MicroRNA)IBA
01/2016 - 11/2015
2Sulindac (Copal)FDA LinkGeneric
06/2014 - 11/2012
2Celecoxib (Celebrex)FDA Link
03/2014 - 03/2013

Therapy/Procedure

63Therapeutics
11/2023 - 06/2003
13Radiotherapy
10/2021 - 06/2003
13Drug Therapy (Chemotherapy)
11/2020 - 06/2003
5Immunotherapy
01/2022 - 11/2009
5Chemoprevention
12/2019 - 02/2011
4Precision Medicine
10/2023 - 01/2016
4Chemoradiotherapy
11/2020 - 02/2009
3Microbubbles
01/2024 - 01/2015
2Neoadjuvant Therapy
01/2023 - 11/2012
2Aftercare (After-Treatment)
01/2017 - 01/2015
2Oral Administration
03/2015 - 10/2012
2Molecular Targeted Therapy
04/2014 - 01/2013